Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_4040Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU50% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4041Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU42% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4042Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU38% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4043Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU30% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4044Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU22% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4045Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU20% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4046Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoResearch institute of fundamental and clinical immunology, RussiaHuman non-small lung carcinoma cell lineA54910000 cells per wellNAMTT assay2 HAU30% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4047Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoResearch institute of fundamental and clinical immunology, RussiaHuman non-small lung carcinoma cell lineA54910000 cells per wellNAMTT assay8 HAU42% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4048Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoResearch institute of fundamental and clinical immunology, RussiaHuman non-small lung carcinoma cell lineA54910000 cells per wellNAMTT assay16 HAU39% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4049Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoRussian academy of science, RussiaHuman breast cancer adenocarcinoma cell lineMCF-710000 cells per wellNAMTT assay2 HAU79% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4050Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoRussian academy of science, RussiaHuman breast cancer adenocarcinoma cell lineMCF-710000 cells per wellNAMTT assay8 HAU80% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4051Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoRussian academy of science, RussiaHuman breast cancer adenocarcinoma cell lineMCF-710000 cells per wellNAMTT assay16 HAU80% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4052Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU38% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4053Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU35% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4054Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU30% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4055Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU58% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4056Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU50% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4057Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU60% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4058Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoResearch institute of fundamental and clinical immunology, RussiaHuman non-small lung carcinoma cell lineA54910000 cells per wellNAMTT assay2 HAU45% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4059Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoResearch institute of fundamental and clinical immunology, RussiaHuman non-small lung carcinoma cell lineA54910000 cells per wellNAMTT assay8 HAU20% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4060Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoResearch institute of fundamental and clinical immunology, RussiaHuman non-small lung carcinoma cell lineA54910000 cells per wellNAMTT assay16 HAU20% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4061Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoRussian academy of science, RussiaHuman breast cancer adenocarcinoma cell lineMCF-710000 cells per wellNAMTT assay2 HAU62% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4062Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoRussian academy of science, RussiaHuman breast cancer adenocarcinoma cell lineMCF-710000 cells per wellNAMTT assay8 HAU62% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4063Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoRussian academy of science, RussiaHuman breast cancer adenocarcinoma cell lineMCF-710000 cells per wellNAMTT assay16 HAU62% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4064Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU68% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4065Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU65% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4066Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU62% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4067Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay2 HAU50% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4068Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay8 HAU50% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4069Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoInstitute of clinical and experimental lymphology, RussiaHuman epitheloid cervix carcinomaHeLa10000 cells per wellNAMTT assay16 HAU45% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4070Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoResearch institute of fundamental and clinical immunology, RussiaHuman non-small lung carcinoma cell lineA54910000 cells per wellNAMTT assay2 HAU40% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4071Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoResearch institute of fundamental and clinical immunology, RussiaHuman non-small lung carcinoma cell lineA54910000 cells per wellNAMTT assay8 HAU38% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4072Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoResearch institute of fundamental and clinical immunology, RussiaHuman non-small lung carcinoma cell lineA54910000 cells per wellNAMTT assay16 HAU38% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4073Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoRussian academy of science, RussiaHuman breast cancer adenocarcinoma cell lineMCF-710000 cells per wellNAMTT assay2 HAU90% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4074Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoRussian academy of science, RussiaHuman breast cancer adenocarcinoma cell lineMCF-710000 cells per wellNAMTT assay8 HAU90% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4075Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoRussian academy of science, RussiaHuman breast cancer adenocarcinoma cell lineMCF-710000 cells per wellNAMTT assay16 HAU80% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4076Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoResearch institute of fundamental and clinical immunology, RussiaHuman non-small lung carcinoma cell lineA549NANANANANASCID mice xenograft for A459 cell (3.5E+6)16 HAUNA 4.2 fold decrease in tumor size compared to control after 15th dayNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4369Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman skin metastasisSK-MEL-22000 cells per wellNALuciferase based ATP assay0.013 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4370Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman axillary node metastasisSKMEL-51000 cells per wellNALuciferase based ATP assay0.017 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4371Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoATCCHuman filamin-1 transfected M2 skin melanoma cell lineA7500 cells per wellNALuciferase based ATP assay0.020 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4372Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman lung metastasis cell lineMALME-3M1000 cells per wellNALuciferase based ATP assay0.038 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4373Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman malignant melanoma cell lineUACC-2571000 cells per wellNALuciferase based ATP assay0.083 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4374Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman malignant melanoma cell lineSK-MEL-28500 cells per wellNALuciferase based ATP assay0.257 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4375Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoATCCHuman lymph node metastasis cell lineSKMEL-31000 cells per wellNALuciferase based ATP assay0.286 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4376Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoATCCHuman bowes melanoma cell lineHMCB750 cells per wellNALuciferase based ATP assay0.310 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4377Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman lymph node metastasis cell lineLOX-IMVI1000 cells per wellNALuciferase based ATP assay0.788 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4378Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman malignant melanoma cell lineUCSD-24L500 cells per wellNALuciferase based ATP assay0.798 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4379Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoATCCHuman primary melanoma cell lineA375250 cells per wellNALuciferase based ATP assay0.948 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4380Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman malignant melanoma cell lineUACC-62500 cells per wellNALuciferase based ATP assay1 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4381Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoATCCHuman lymph node metastasis cell lineRPMI-7951500 cells per wellNALuciferase based ATP assay2.565 MOI50% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4382Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman skin metastasisSK-MEL-22000 cells per wellNALuciferase based ATP assay0.058 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4383Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman axillary node metastasisSKMEL-51000 cells per wellNALuciferase based ATP assay0.065 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4384Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoATCCHuman filamin-1 transfected M2 skin melanoma cell lineA7500 cells per wellNALuciferase based ATP assay0.363 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4385Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman lung metastasis cell lineMALME-3M1000 cells per wellNALuciferase based ATP assay0.155 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4386Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman malignant melanoma cell lineUACC-2571000 cells per wellNALuciferase based ATP assay0.370 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4387Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman malignant melanoma cell lineSK-MEL-28500 cells per wellNALuciferase based ATP assay0.922 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4388Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoATCCHuman lymph node metastasis cell lineSKMEL-31000 cells per wellNALuciferase based ATP assay1.80 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4389Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoATCCHuman bowes melanoma cell lineHMCB750 cells per wellNALuciferase based ATP assay6.10 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4390Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman lymph node metastasis cell lineLOX-IMVI1000 cells per wellNALuciferase based ATP assay6 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4391Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman malignant melanoma cell lineUCSD-24L500 cells per wellNALuciferase based ATP assay2.25 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4392Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoATCCHuman primary melanoma cell lineA375250 cells per wellNALuciferase based ATP assay4.43 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4393Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoNCIHuman malignant melanoma cell lineUACC-62500 cells per wellNALuciferase based ATP assay2.46 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4394Newcastle disease virusMTH-68/HRNAParamyxoviridaeNoneYesNoNoATCCHuman lymph node metastasis cell lineRPMI-7951500 cells per wellNALuciferase based ATP assay8.80 MOI80% cancer cell deathNoNoNA No responseNAER stress and apoptotic pathwayIFN production increasedNA26408702
OV_4490Newcastle disease viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit0.0001 MOI50% cell viablity after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4491Newcastle disease viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit0.01 MOI30% cell viablity after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4492Newcastle disease viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit0.1 MOI100% cell death after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4493Newcastle disease viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit1 MOI100% cell death after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4494Newcastle disease viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit10 MOI100% cell death after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4495Newcastle disease virus73T-S-KmRNAParamyxoviridaeInsertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotideYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit0.0001 MOI80% cell viablity after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4496Newcastle disease virus73T-S-KmRNAParamyxoviridaeInsertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotideYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit0.01 MOI38% cell viablity after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4497Newcastle disease virus73T-S-KmRNAParamyxoviridaeInsertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotideYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit0.1 MOI15% cell viablity after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4498Newcastle disease virus73T-S-KmRNAParamyxoviridaeInsertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotideYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit1 MOI100% cell death after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4499Newcastle disease virus73T-S-KmRNAParamyxoviridaeInsertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotideYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit10 MOI100% cell death after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4500Newcastle disease virus73T-R-198RNAParamyxoviridaeInsertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotideYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit0.0001 MOI50% cell viablity after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4501Newcastle disease virus73T-R-198RNAParamyxoviridaeInsertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotideYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit0.01 MOI20% cell viablity after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4502Newcastle disease virus73T-R-198RNAParamyxoviridaeInsertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotideYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit0.1 MOI100% cell death after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4503Newcastle disease virus73T-R-198RNAParamyxoviridaeInsertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotideYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit1 MOI100% cell death after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4504Newcastle disease virus73T-R-198RNAParamyxoviridaeInsertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotideYesNoNoATCCHuman fibroblast sarcoma cell lineHT10805.0E+3 cells per wellNACell titer glo kit10 MOI100% cell death after 72 hoursNoNoNA No responseNANAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4505Newcastle disease viruswild typeRNAParamyxoviridaeNoneYesNoNoNANANANANANANANAAthymic nude mice xenograft for HT1080 (5.0E+6)2.0E+7 pfuNA Tumor volume reduced to 300 cubic mm after 25 days compared to control 800 cubic mmIntratumoralNAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4506Newcastle disease virus73T-S-KmRNAParamyxoviridaeInsertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotideYesNoNoNANANANANANANANAAthymic nude mice xenograft for HT1080 (5.0E+6)2.0E+7 pfuNA Tumor volume reduced to below 100 cubic mm after 25 days compared to control 800 cubic mmIntratumoralNAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4507Newcastle disease virus73T-R-198RNAParamyxoviridaeInsertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotideYesNoNoNANANANANANANANAAthymic nude mice xenograft for HT1080 (5.0E+6)2.0E+7 pfuNA Tumor volume reduced to 300 cubic mm after 25 days compared to control 800 cubic mmIntratumoralNAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4508Newcastle disease virus73T-R-198RNAParamyxoviridaeInsertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotideYesNoNoNANANANANANANANAAthymic nude mice xenograft for HT1080 (5.0E+6)1.0E+8 pfuNA Tumor volume reduced to below 500 cubic mm compared to control 1000 cubic mm after 25 daysIntravenousNAInduced expression of Type 1 IFN, NK cells and macrophagesNA27009956
OV_4945Newcastle disease virusNDV/AnhRNAParamyxoviridaeNoneYesNoNoHarbin phamaceutical group bioengineeringNANANANANANANANude mice xenograft for H22 cell line (1.0E+5 cells)1.0E+7 pfu every other day for four timesNA Average volume in control mice was 3401.25 cubic mm and decreased to 1489.97 cubuc mm in treated miceIntratumoralNAActivate T cellsNA27174862
OV_4946Newcastle disease virusNDV/Anh-IL2RNAParamyxoviridaeInsertion of IL-2 gene between HN and L gene of pAnh-wtYesNoExpressing Il-2 geneHarbin phamaceutical group bioengineeringNANANANANANANANude mice xenograft for H22 cell line (1.0E+5 cells)1.0E+7 pfu every other day for four timesNA Average volume in control mice was 3401.25 cubic mm and decreased to 420.67 cubuc mm in treated mice, while 3 out of 6 complete regressed tumor volumeIntratumoralNAActivate T cellsNA27174862
OV_5334Newcastle disease virusNDV/Anh-TRAILRNAParamyxoviridaeVirus insertion for TRAIL geneYesNoNoChina Xiehe Medical UniversityHuman hepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay0.01 MOI56.7% cells remain viableNoNoNA No responseNAVirus induced apoptosis as measured by TUNEL assayCaspase 3 pathway are activatedNA28246027
OV_5335Newcastle disease virusNDV/Anh-TRAILRNAParamyxoviridaeVirus insertion for TRAIL geneYesNoNoChina Xiehe Medical UniversityHuman hepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay0.1 MOI43.2% cells remain viableNoNoNA No responseNAVirus induced apoptosis as measured by TUNEL assayCaspase 3 pathway are activatedNA28246027
OV_5336Newcastle disease virusNDV/Anh-TRAILRNAParamyxoviridaeVirus insertion for TRAIL geneYesNoNoChina Xiehe Medical UniversityHuman hepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay1 MOI29.6% cells remain viableNoNoNA No responseNAVirus induced apoptosis as measured by TUNEL assayCaspase 3 pathway are activatedNA28246027
OV_5337Newcastle disease virusNDV/Anh-TRAILRNAParamyxoviridaeVirus insertion for TRAIL geneYesNoNoChina Xiehe Medical UniversityHuman hepatocellular carcinoma cell lineHepG21.0E+4 cells per wellNAMTT assay10 MOI20.8% cell growth inhibitionNoNoNA No responseNAVirus induced apoptosis as measured by TUNEL assayCaspase 3 pathway are activatedNA28246027
OV_5338Newcastle disease virusNDV/Anh-TRAILRNAParamyxoviridaeVirus insertion for TRAIL geneYesNoNoNANANANANANANANAKumming mice implanted for 5.0E+5 H22 cells1.0E+7 pfuNA Reduction in tumor volume to 10 cubic mm compared to control 3500 cubic mm after 14 daysIntratumoralVirus induced apoptosis as measured by TUNEL assayCaspase 3 pathway are activatedNA28246027
OV_5339Newcastle disease virusLaSotaRNAParamyxoviridaeNoneYesNoNoATCCHuman nonsmall cell lung carcinomaA5495.0E+4 cells per wellNAMTT assay0.001 MOI16% cells remain viable after 72 hoursNoNoNA No responseNAVirus induce apoptosisInduced production of IFN-alpha, IFN-beta, IL-6and IFN-gammaNA28293547
OV_5340Newcastle disease virusLaSotaRNAParamyxoviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-75.0E+4 cells per wellNAMTT assay0.001 MOI37% cells remain viable after 72 hoursNoNoNA No responseNAVirus induce apoptosisInduced production of IFN-alpha, IFN-beta, IL-6and IFN-gammaNA28293547
OV_5341Newcastle disease virusLaSotaRNAParamyxoviridaeNoneYesNoNoATCCHuman glioblastoma multiformeU-87 MG5.0E+4 cells per wellNAMTT assay0.001 MOI19% cells remain viable after 72 hoursNoNoNA No responseNAVirus induce apoptosisInduced production of IFN-alpha, IFN-beta, IL-6and IFN-gammaNA28293547
OV_5342Newcastle disease virusLaSotaRNAParamyxoviridaeNoneYesNoNoATCCHuman mammary gland adenocarcinomaMDA-MB-4535.0E+4 cells per wellNAMTT assay0.001 MOI35% cells remain viable after 72 hoursNoNoNA No responseNAVirus induce apoptosisInduced production of IFN-alpha, IFN-beta, IL-6and IFN-gammaNA28293547
OV_5343Newcastle disease virusLaSotaRNAParamyxoviridaeNoneYesNoNoATCCHuman glioblastoma multiformeT98G5.0E+4 cells per wellNAMTT assay0.001 MOI29% cells remain viable after 72 hoursNoNoNA No responseNAVirus induce apoptosisInduced production of IFN-alpha, IFN-beta, IL-6and IFN-gammaNA28293547
OV_5344Newcastle disease virusLaSotaRNAParamyxoviridaeNoneYesNoNoATCCHuman mammary gland adenocarcinomaMCF-75.0E+4 cells per wellNAMTT assay0.001 MOI44% cells remain viable after 72 hoursNoNoNA No responseNAVirus induce apoptosisInduced production of IFN-alpha, IFN-beta, IL-6and IFN-gammaNA28293547
OV_5591Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman fibrosarcoma cell lineHT108080% confluencyNAMTT assay2 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5592Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman pancreatic carcinoma cell linePANC-180% confluencyNAMTT assay3 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5593Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman renal carcinoma cell lineCAKI-180% confluencyNAMTT assay8 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5594Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman renal carcinoma cell lineCAKI-180% confluencyNAMTT assay11 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5595Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman renal carcinoma cell lineA49880% confluencyNAMTT assay15 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426